Creabilis Raises $20M Series B
European biotech company Creabilis has raised $20 million in a Series B financing round led by Abbott Biotech Ventures. Existing investors Neomed and Sofinnova Partners also joined in the round, which will help finance development efforts.
4 October 2011•2 mins read
